First: did it come from a licensed US pharmacy?
The vast majority of counterfeit GLP-1 pens reach patients through unlicensed online sellers, social-media "pharmacies," and grey-market resellers — not through a US-licensed pharmacy. So the first question isn’t about the pen at all; it’s about where it came from. A pen dispensed by a licensed US pharmacy against a valid prescription is very unlikely to be fake, while a pen bought from an overseas website, a social-media DM, or a "no prescription needed" site should be treated as suspect until proven otherwise.
If you are not sure a seller is legitimate, verify it before you ever inject — our guide on how to verify an online pharmacy walks through the checks. If the pen came from a source you can’t stand behind, do not use it.
Match your lot number against the FDA list
Every Ozempic carton and pen is printed with a lot number and a serial number. Find them on the carton and on the pen label, and compare the lot against the FDA-flagged lots in the table above. Two of the flagged lots — PAR0362 and PAR1229 — are real Novo Nordisk lot numbers, so seeing them is not proof of a fake; the counterfeit signal is a flagged lot combined with the wrong serial, or the physical tells below.
Because new counterfeit waves can be announced at any time, treat this list as a dated snapshot. Confirm the current list on the FDA’s counterfeit-Ozempic alert page before relying on it, and when a lot or serial is in question, read them to Novo Nordisk over the phone rather than guessing.
Inspect the pen, label, and needle
Beyond the lot number, FDA and Novo Nordisk have described physical tells on the counterfeits. Use these as warning signs — any one of them is a reason to stop and verify, not to inject and hope.
- Label text placement: on the Dec 2025 (PAR1229) fakes, the "EXP" and "LOT" text sits to the LEFT of the date; on a genuine pen it prints ABOVE the date.
- Misspellings, blurry or crooked printing, mismatched fonts, or a pen label that peels or looks like a sticker over another label.
- The pen itself: a dose selector or pen body that looks or feels different from a previous genuine pen, or that doesn’t click and set doses the way yours normally does.
- The needle: counterfeit needles have been reported that don’t fit properly or whose sterility can’t be confirmed — a serious infection risk. If the needle looks or fits wrong, don’t use it.
- The carton and paperwork: missing Medication Guide, altered NDC, or a carton that doesn’t match the pen inside.
If your pen looks suspect — what to do
If any of the above applies, treat the pen as unsafe. The goal is to avoid injecting an unknown substance with a possibly non-sterile needle, and to get the counterfeit into the hands of the people who track it.
- Do not inject it. Set it aside; don’t throw it away yet — it may be needed to verify.
- Call Novo Nordisk Customer Care at 1-800-727-6500 (Mon–Fri, 8:30am–6:00pm ET) with the lot and serial ready; they can help authenticate the pen.
- Report it to the FDA through MedWatch — online or at 1-800-FDA-1088. Our guide on reporting a problem to the FDA walks through the form.
- Tell the pharmacy that dispensed it, so they can check their own stock and supplier.
- If you already injected a pen you now doubt and feel unwell — especially signs of infection at the injection site, or symptoms of very low blood sugar — seek medical care.